Zynex Price to Free Cash Flow Ratio 2010-2025 | ZYXI
Historical price to free cash flow ratio values for Zynex (ZYXI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zynex Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-03 | 2.40 | 0.00 | |
| 2025-03-31 | 2.20 | $-0.02 | 0.00 |
| 2024-12-31 | 8.01 | $0.38 | 21.30 |
| 2024-09-30 | 8.16 | $0.46 | 17.59 |
| 2024-06-30 | 9.32 | $0.49 | 19.10 |
| 2024-03-31 | 12.37 | $0.47 | 26.29 |
| 2023-12-31 | 10.89 | $0.46 | 23.71 |
| 2023-09-30 | 8.00 | $0.42 | 18.94 |
| 2023-06-30 | 9.59 | $0.37 | 26.05 |
| 2023-03-31 | 12.00 | $0.35 | 34.60 |
| 2022-12-31 | 13.91 | $0.34 | 40.84 |
| 2022-09-30 | 9.07 | $0.41 | 22.11 |
| 2022-06-30 | 7.98 | $0.31 | 25.40 |
| 2022-03-31 | 6.23 | $0.35 | 17.87 |
| 2021-12-31 | 8.14 | $0.16 | 50.34 |
| 2021-09-30 | 9.30 | $-0.08 | 0.00 |
| 2021-06-30 | 12.68 | $-0.19 | 0.00 |
| 2021-03-31 | 12.47 | $-0.16 | 0.00 |
| 2020-12-31 | 10.99 | $0.00 | 0.00 |
| 2020-09-30 | 14.25 | $0.10 | 141.48 |
| 2020-06-30 | 20.31 | $0.17 | 116.50 |
| 2020-03-31 | 9.04 | $0.13 | 71.17 |
| 2019-12-31 | 6.43 | $0.16 | 39.09 |
| 2019-09-30 | 7.76 | $0.17 | 44.73 |
| 2019-06-30 | 7.34 | $0.20 | 36.25 |
| 2019-03-31 | 3.67 | $0.25 | 14.90 |
| 2018-12-31 | 2.40 | $0.22 | 10.80 |
| 2018-09-30 | 2.36 | $0.26 | 9.20 |
| 2018-06-30 | 2.46 | $0.25 | 9.72 |
| 2018-03-31 | 2.69 | $0.25 | 10.89 |
| 2017-12-31 | 2.52 | $0.22 | 11.26 |
| 2017-09-30 | 1.47 | $0.14 | 10.69 |
| 2017-06-30 | 0.48 | $0.07 | 6.53 |
| 2017-03-31 | 0.24 | $0.02 | 9.97 |
| 2016-12-31 | 0.24 | $0.04 | 5.30 |
| 2016-09-30 | 0.25 | $0.04 | 6.16 |
| 2016-06-30 | 0.19 | $0.04 | 4.98 |
| 2016-03-31 | 0.27 | $0.02 | 10.82 |
| 2015-12-31 | 0.36 | $0.01 | 35.21 |
| 2015-09-30 | 0.14 | $-0.01 | 0.00 |
| 2015-06-30 | 0.16 | $-0.01 | 0.00 |
| 2015-03-31 | 0.11 | $0.03 | 4.28 |
| 2014-12-31 | 0.13 | $0.02 | 6.51 |
| 2014-09-30 | 0.12 | $0.04 | 2.90 |
| 2014-06-30 | 0.23 | $0.04 | 6.46 |
| 2014-03-31 | 0.18 | $0.00 | 0.00 |
| 2013-12-31 | 0.15 | $-0.03 | 0.00 |
| 2013-09-30 | 0.11 | $-0.04 | 0.00 |
| 2013-06-30 | 0.20 | $-0.04 | 0.00 |
| 2013-03-31 | 0.24 | $-0.05 | 0.00 |
| 2012-12-31 | 0.29 | $-0.05 | 0.00 |
| 2012-09-30 | 0.33 | $-0.04 | 0.00 |
| 2012-06-30 | 0.34 | $-0.05 | 0.00 |
| 2012-03-31 | 0.33 | $-0.05 | 0.00 |
| 2011-12-31 | 0.28 | $-0.05 | 0.00 |
| 2011-09-30 | 0.32 | $-0.06 | 0.00 |
| 2011-06-30 | 0.36 | $-0.04 | 0.00 |
| 2011-03-31 | 0.29 | $-0.04 | 0.00 |
| 2010-12-31 | 0.24 | $-0.04 | 0.00 |
| 2010-09-30 | 0.21 | $0.02 | 10.51 |
| 2010-06-30 | 0.24 | $0.03 | 9.39 |
| 2010-03-31 | 0.37 | $0.04 | 9.69 |
| 2009-12-31 | 0.43 | $0.08 | 5.37 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.073B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |